Bill > S2697

This bill authorizes the National Science Foundation (NSF) to establish a comprehensive research program on biotechnology risk assessment. The bill recognizes the widespread use of biotechnology in modifying genetic sequences across various sectors and aims to support research that helps government agencies, industries, and stakeholders better understand and manage potential risks. Specifically, the NSF will create a program within its Directorate for Technology, Innovation, and Partnerships to fund research examining environmental, human health, and animal health risks associated with biotechnology-produced organisms. The bill outlines detailed research priorities, including identifying unintended genetic changes, developing risk management practices, monitoring gene dispersal, and exploring potential risks from emerging technologies like artificial intelligence. The program will fund research through various mechanisms like grants and research consortia, with eligible recipients including universities, research centers, nonprofit institutions, and private sector entities. Additionally, the bill mandates a two-phase study by the National Academies of Science, Engineering, and Medicine to comprehensively assess biotechnology's safety and benefits, with required reports to Congress. The legislation authorizes $50 million annually from fiscal years 2026-2030 for the NSF research program and $1.5 million for the National Academies study, demonstrating a significant federal commitment to understanding biotechnology's potential risks and opportunities.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/2697/all-info